Cargando…
The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant Pain
Chronic nonmalignant pain (CNMP), defined as persistent pain that is not attributable to a potentially life-limiting condition and has a duration of at least 3 months, is widespread in the United States. Moderate-to-severe CNMP often is treated with opioid analgesics, and there is ongoing debate reg...
Autores principales: | Lipman, Arthur, Webster, Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397831/ https://www.ncbi.nlm.nih.gov/pubmed/26402389 http://dx.doi.org/10.18553/jmcp.2015.21.10.891 |
Ejemplares similares
-
Medical Cannabis for Chronic Nonmalignant Pain Management
por: Hameed, Maha, et al.
Publicado: (2023) -
A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain
por: Tabuchi, Yukiko, et al.
Publicado: (2012) -
Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?
por: Kissin, Igor
Publicado: (2013) -
Cost of Pain Medication to Treat Adult Patients with Nonmalignant Chronic Pain in the United States
por: Rasu, Rafia S., et al.
Publicado: (2014) -
Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study
por: Wallace, M, et al.
Publicado: (2007)